Hemorrhagic cholecystitis --a rare cause of hemobilia and melena --is an atypical presentation of calculous cholecystitis, associated with significant morbidity and mortality. A 75-year-old woman with multiple comorbidities, who was undergoing dual antiplatelet therapy, presented with symptoms of acute cholecystitis. Two days later, she developed melena and symptoms of obstructive jaundice. Following radiological evaluation, a diagnosis of hemorrhagic cholecystitis was made. The patient was managed conservatively with IV antibiotics and blood transfusion in the initial period (clopidogrel was withheld); an interval cholecystectomy was performed six weeks later. Hemorrhagic cholecystitis is a rare complication of acute cholecystitis, and its diagnosis is challenging as it mimics various other hepatopancreaticobiliary diseases. Management options include early surgery or conservative management at the initial stage, followed by interval cholecystectomy.

No abstract

Dilated Cardiomyopathy (DCM) in adults is mostly an idiopathic disease with a progressive and irreversible course. It usually carries a poor prognosis [1]. Rarely, a reversible metabolic etiology amenable to specific therapy is identified [1]. There are few cardiovascular abnormalities that are commonly encountered in patients with renal impairment; these include LVH, LV dilatation, and LV systolic and diastolic dysfunction [2]. Here, we report a case of 36 year-old female with reversible uremic cardiomyopathy due to obstructive uropathy due to moderately differentiated squamous cell type metastatic cervical carcinoma which completely responded to bilateral ureteric stenting.